Twist Bioscience Corporation
TWST • NASDAQ
Twist Bioscience Corporation is a medical - diagnostics & research company in the healthcare sector trading on NASDAQ, led by CEO Emily Marine Leproust, with a market cap of $2.7B.
CEOEmily Marine Leproust
Next Earnings
Upcoming earnings announcement for Twist Bioscience Corporation
Date
Monday, May 4, 2026 (in a month)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q2 2026
EPS Estimate
-$0.53
Revenue Estimate
$107.7M
Earnings History
Past 12 earnings reports for Twist Bioscience Corporation
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 2, 2026 | Q1 2026 | -$0.50Est: -$0.50 | 0.0% | $103.7MEst: $102.7M | +0.9% |  10-Q |
| Nov 14, 2025 | Q4 2025 | -$0.45Est: -$0.46 | +2.2% | $99.0MEst: $97.4M | +1.7% | 10-K |
| Aug 4, 2025 | Q3 2025 | -$0.47Est: -$0.56 | +16.1% | $96.1MEst: $95.6M | +0.5% | 10-Q |
| May 5, 2025 | Q2 2025 | -$0.66Est: -$0.56 | -17.9% | $92.8MEst: $92.0M | +0.8% | 10-Q |
| Feb 3, 2025 | Q1 2025 | -$0.53Est: -$0.63 | +15.9% | $88.7MEst: $87.0M | +2.0% | 10-Q |
| Nov 18, 2024 | Q4 2024 | -$0.59Est: -$0.69 | +14.5% | $84.7MEst: $82.7M | +2.5% | 10-K |
| Aug 2, 2024 | Q3 2024 | -$0.70Est: -$0.77 | +9.1% | $81.5MEst: $77.3M | +5.4% | 10-Q |
| May 2, 2024 | Q2 2024 | -$0.79Est: -$0.81 | +2.5% | $75.3MEst: $70.7M | +6.6% | 10-Q |
| Feb 2, 2024 | Q1 2024 | -$0.75Est: -$0.78 | +3.8% | $71.5MEst: $67.6M | +5.8% | 10-Q |
| Nov 17, 2023 | Q4 2023 | -$0.81Est: -$0.92 | +12.0% | $66.9MEst: $63.5M | +5.5% | — |
| Aug 4, 2023 | Q3 2023 | -$1.01Est: -$1.14 | +11.4% | $63.7MEst: $60.7M | +5.0% | 10-Q |
| May 5, 2023 | Q2 2023 | -$1.04Est: -$1.12 | +7.1% | $60.2MEst: $56.7M | +6.2% | — |